US Pharma MarketingCDER chief Høeg, a skeptic of vaccines and antidepressants, expected to leave FDA, according to source
FDA acting drug chief Tracy Beth Høeg, a vaccine skeptic aligned with HHS Secretary RFK Jr., is expected to depart following Commissioner Marty Makary Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing:…
The leader of the FDA's drug division, Tracy Beth Høeg, is expected to depart the agency following the recent exit of Commissioner Marty Makary, according to a source familiar with the matter.
Høeg was
Source: Endpoints News